START
Return
Access
National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use
American Society of Addiction Medicine (ASAM)
The American Society of Addiction Medicine (ASAM) developed this National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use to provide information on evidence-based treatment of opioid use disorder. This guideline is the only document of its kind to include all FDA-approved medications in one place. The National Practice Guideline supplement is the journal version of the original National Practice Guideline.
The European Commission is preparing a third phase of this programme, therefore COPOLAD will be back at the beginning of 2021.